Skip to main content

XTNT

Xtant Medical Holdings, Inc.

Company with tickers: XTNT

Market Cap
$59.12M
Shares Outstanding
140,262,960
CIK
1453593
CUSIP
98420P308
13F Activity (30d)
1 filings 1 filers
Investor Relations
Investor relations

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Line Item Value
Revenue
Revenue (ASC 606) $20,884,000
Interest & Dividend Income
Net Interest Income
Noninterest Income
Total Net Revenue
Premiums Earned (Net)
Cost of Revenue
Gross Profit $11,971,000
Operating Expenses $14,894,000
Research & Development $435,000
Operating Income $-2,923,000
Net Income $-3,089,000
EPS (Basic) $-0.02
EPS (Diluted) $-0.02

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

By Geography (USD)

Component 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
United States $52,147,000 $54,570,000 $57,162,000 $85,862,000 $105,519,000 $122,448,000
Non Us $11,748,000 $11,479,000
Rest Of World $1,190,000 $693,000 $807,000 $5,441,000

By Product & Service (USD)

Component 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Product $115,204,000
Orthobiologics $39,308,000 $42,259,000 $47,143,000 $58,605,000 $66,419,000 $72,892,000
Spinal Implant $13,880,000 $12,887,000 $10,826,000 $32,698,000 $49,346,000 $42,312,000
License $1,502,000 $18,723,000
License Revenue $18,723,000
Bill And Hold Transactions $400,000
Other Revenue $149,000 $117,000